PAPERS - RESEARCH FRONT: 9
| TITLE | 1ST AUTHOR | YEAR |
| THEORETICAL-STUDIES OF SEQUENCE EFFECTS ON THE CONFORMATIONAL PROPERTIES OF A FRAGMENT OF THE PRION PROTEIN - IMPLICATION FOR SCRAPIE FORMATION |
KAZMIRSKI SL |
1995 |
| X-RAY-DIFFRACTION OF SCRAPIE PRION RODS AND PRP PEPTIDES |
NGUYEN JT |
1995 |
| A MUTANT PRION PROTEIN DISPLAYS AN ABERRANT MEMBRANE ASSOCIATION WHEN EXPRESSED IN CULTURED-CELLS |
LEHMANN S |
1995 |
| Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein |
Petersen RB |
1996 |
| Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein |
Williamson RA |
1996 |
| Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells |
Daude N |
1997 |
| X-ray diffraction analysis of scrapie prion: Intermediate and folded structures in a peptide containing two putative alpha-helices |
Inouye H |
1997 |
| Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform |
James TL |
1997 |
| A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform |
Peretz D |
1997 |
| Pathologic conformations of prion proteins |
Cohen FE |
1998 |
| Polymerization of human prion peptide HuPrP 106-126 to amyloid in nucleic acid solution |
Nandi PK |
1998 |
| The three-dimensional structure of prion protein: implications for prion disease |
Baldwin MA |
1998 |
| Mapping the prion protein using recombinant antibodies |
Williamson RA |
1998 |
| Familial mutations and the thermodynamic stability of the recombinant human prion protein |
Swietnicki W |
1998 |
| Polymerization of murine recombinant prion protein in nucleic acid solution |
Nandi PK |
1999 |
| Thermodynamics of model prions and its implications for the problem of prion protein folding |
Harrison PM |
1999 |
| A chicken monoclonal antibody with specificity for the N-terminal of human prion protein |
Matsuda H |
1999 |
| Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: Implications for the mechanism of prion formation |
Cappai R |
1999 |
| Solution structure of Syrian hamster prion protein rPrP(90-231) |
Liu H |
1999 |
| Antibody binding defines a structure for an epitope that participates in the PrPC -> PrPSc conformational change |
Kanyo ZF |
1999 |
| NMR solution structure of the human prion protein |
Zahn R |
2000 |
| A synthetic peptide initiates Gerstmann-Straussler-Scheinker (GSS) disease in transgenic mice |
Kaneko K |
2000 |
| Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein |
Zulianello L |
2000 |
| Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP - Effect of protein age and deamidation |
Qin KF |
2000 |
| Effect of the E200K mutation on prion protein metabolism - Comparative study of a cell model and human brain |
Capellari S |
2000 |
| Solution structure of the E200K variant of human prion protein - Implications for the mechanism of pathogenesis in familial prion diseases |
Zhang YB |
2000 |
| Molecular dynamics simulations of wild-type and point mutation human prion protein at normal and elevated temperature |
El-Bastawissy E |
2001 |
| In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies |
Yokoyama T |
2001 |
| Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: Dependence of conformation on pH |
Matsunaga Y |
2001 |
| Crystal structure of the human prion protein reveals a mechanism for oligomerization |
Knaus KJ |
2001 |
| Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration |
Laws DD |
2001 |
| Engineering the prion protein using chemical synthesis |
Ball HL |
2001 |
| Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA |
Moscardini M |
2002 |
| Prion protein interactions with nucleic acid: Possible models for prion disease and prion function |
Grossman A |
2003 |
| Characterization of 2 '-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion |
Rhie A |
2003 |
| The effect of disease-associated mutations on the folding pathway of human prion protein |
Apetri AC |
2004 |
| Establishment of a chicken monoclonal antibody panel against mammalian prion protein |
Nakamura N |
2004 |